Every SEC Form 3/4/5 on record for this filer (CIK 1339484) — 2 issuers, 6 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| CLDI | Calidi Biotherapeutics, Inc. | Chief Executive Officer | 2025-04-25 → 2025-09-05 | 4 | $50,000 |
| MTEM | Molecular Templates, Inc. | See remarks · Director · lapsed | 2017-08-11 → 2024-01-25 | 13 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| CLDI | 2025-08-21 | Buy | 25,000 | $2.00 | $50,000 | 25,000 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.
